Search
Returning search results with filters:
Remove filter for
Audience: Health professionals
Remove filter for
Category: Biologic or vaccine
Remove filter for
Issue: New safety information
Remove filter for
Issue: COVID
Remove filter for
Last updated: October 2022
Remove filter for
Last updated: 2022
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 1 of 1 items.
EVUSHELD (tixagevimab and cilgavimab for injection) - Risk of Prophylaxis or Treatment Failure due to Antiviral Resistance
AlertHealth professional risk communication | 2022-10-26